MENU
VIR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Vir Biotechnology (VIR) Ownership - Who owns Vir Biotechnology?
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases... Show more
Profile
Industry
N/A
Address
1800 Owens Street
Phone
+1 415 906-4324
Employees
587
Web
https://www.vir.bio
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
800.77M
P/E Ratio
N/A
Total Cash
905.35M
Projected Growth
N/A
Total Debt
97.89M
Revenue
63.71M
Risk (Beta)
1.99
Dividend Yield
N/A
Total Cash/Share
6.56
Total Debt/Equity
N/A
Revenue/Share
0.47 USD as % of share price
Fundamentals
VIR
Capitalization
801M
P/E Ratio
N/A
Risk (Beta)
1.99
Dividend Yield
N/A
Total Cash
905M
Total Cash/Share
6.56
Total Debt
97.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.47%
Revenue
63.7M
ROE
N/A
Book Value
1.15B
P/B Ratio
0.70
Cash Flow
N/A
Earnings
-3.83
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
14K
Current Ratio
8.71
Current Revenue Per Employee
27642.16
Dividends Per Share - Security
N/A
EBITDA
-537.61M
Float
N/A
Float - Current
N/A
Gross Income Margin
93.94
Revenue To Assets
-31.46
Shares Held By Institutions
979M
Shares Outstanding - Current
138M
Total Liabilities
248M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-18.801
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1800 Owens Street
Phone
+1 415 906-4324
Employees
587
Web
https://www.vir.bio